Teddi Mellencamp mencari obat penurun berat badan di tengah perjuangan melawan kanker stadium 4

Sabtu, 25 April 2026

Dilaporkan oleh AI

Teddi Mellencamp, mantan bintang Real Housewives of Beverly Hills, mengungkapkan dalam podcast-nya bahwa ia memohon kepada dokternya untuk diberikan obat penurun berat badan GLP-1 saat berjuang melawan kanker. Berat badannya bertambah akibat steroid, namun permintaannya ditolak. Sambil bercanda mengenai ironi tersebut, ia melontarkan komentar jenaka tentang menjalani hidup terbaiknya tanpa bantuan obat tersebut.

Tunggu dulu—Teddi Mellencamp baru saja mengungkapkan cerita jujur dalam podcast 'Two Ts In A Pod'. 😲 Bintang reality show ini mengakui bahwa ia meminta GLP-1 kepada dokternya setelah steroid menyebabkan kenaikan berat badan selama perjuangannya melawan melanoma stadium 4. Namun, dokternya menolak, yang membuatnya merasa frustrasi dengan jenaka: 'Anda menyuruh saya untuk menjalani hidup terbaik saya... tapi di mana GLP-1 saya?' 👀

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Selasa, 05 Mei 2026 Dilaporkan oleh AI Gambar dihasilkan oleh AI Fakta terverifikasi

People who lose weight using GLP-1 medications such as Ozempic and Wegovy may be judged more negatively than those who lose weight through diet and exercise — and even more negatively than people who do not lose weight at all — according to a new study led by Rice University psychologist Erin Standen.

Study links GLP-1 drugs to lower breast cancer risk

Women taking GLP-1 medications such as Ozempic and Wegovy showed about 30 percent lower odds of developing breast cancer in a large observational study.

Trojan horse obesity drug boosts weight loss in mice

Jumat, 08 Mei 2026 Dilaporkan oleh AI

Scientists have developed a hybrid obesity treatment that uses GLP-1 and GIP signals to deliver a metabolic enhancer directly into cells. Early tests in mice showed greater weight loss and better blood sugar control than standard therapies. The approach aims to reduce side effects by limiting the drug's action to targeted areas.

Hiburan

Dolly Martinez of 'My 600-Lb. Life' dies at 30

Gosip

Brandi Glanville defends Lisa Vanderpump against Scheana Shay's memoir

Kesehatan

Study links Ozempic to lower depression and anxiety risks

Katie Thurston shares positive liver cancer update

Katie Thurston received good news in her stage 4 breast cancer battle. Doctors found no evidence of disease in her liver. The Bachelorette star shared the update on her Boobie Broadcast channel.

Japanese study links GLP-1 response to ‘external eating’ habits in people with type 2 diabetes

Jumat, 08 Mei 2026 Dilaporkan oleh AI Fakta terverifikasi

A year-long observational study in Japan suggests that people with type 2 diabetes who tend to overeat in response to tempting food cues such as sight and smell may see greater weight loss—and possibly better blood-sugar improvement—after starting GLP-1 receptor agonists, while those with primarily emotional eating patterns show less consistent links to long-term outcomes.

10 Juni 2026 04.55

Teddi Mellencamp mencari obat penurun berat badan di tengah perjuangan melawan kanker stadium 4

Artikel Terkait

Study finds people who use Ozempic-like drugs for weight loss face added stigma

Study links GLP-1 drugs to lower breast cancer risk

Trojan horse obesity drug boosts weight loss in mice

Dolly Martinez of 'My 600-Lb. Life' dies at 30

Brandi Glanville defends Lisa Vanderpump against Scheana Shay's memoir

Study links Ozempic to lower depression and anxiety risks

Katie Thurston shares positive liver cancer update

Japanese study links GLP-1 response to ‘external eating’ habits in people with type 2 diabetes

Novo Nordisk heads to South African court over semaglutide copies

Kelly Dodd admits secret COVID vaccine and regrets it

Bethenny Frankel claps back at Sports Illustrated runway critics

Mindy Kaling opens up on weight loss and singledom

Brandi Glanville jabs at LeAnn Rimes over housewives rumors

Young Indians risk health with Ozempic, Mounjaro for pre-wedding weight loss

Cleveland Clinic study finds limited weight regain after stopping GLP-1 drugs

Situs web ini menggunakan cookie